Perrigo Company plc $PRGO Stock: State of Alaska Department of Revenue Cuts Stake

State of Alaska Department of Revenue lessened its stake in shares of Perrigo Company plc (NYSE:PRGO) by 59.6% in the third quarter, Holdings Channel reports. The institutional investor owned 23,313 shares of the company’s stock after selling 34,368 shares during the quarter. State of Alaska Department of Revenue’s holdings in Perrigo were worth $344,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of PRGO. Sound Income Strategies LLC grew its stake in Perrigo by 3.9% during the third quarter. Sound Income Strategies LLC now owns 1,615,467 shares of the company’s stock valued at $23,424,000 after acquiring an additional 60,838 shares in the last quarter. Bank of America Corp DE increased its holdings in Perrigo by 25.5% during the 1st quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock worth $16,847,000 after acquiring an additional 318,248 shares during the period. First Trust Advisors LP lifted its stake in Perrigo by 125.5% in the 1st quarter. First Trust Advisors LP now owns 1,496,244 shares of the company’s stock worth $16,070,000 after purchasing an additional 832,686 shares in the last quarter. Gamco Investors INC. ET AL lifted its stake in Perrigo by 29.7% in the 1st quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock worth $15,013,000 after purchasing an additional 320,081 shares in the last quarter. Finally, O Keefe Stevens Advisory Inc. lifted its stake in Perrigo by 9.6% in the 3rd quarter. O Keefe Stevens Advisory Inc. now owns 915,885 shares of the company’s stock worth $13,518,000 after purchasing an additional 80,230 shares in the last quarter. 95.91% of the stock is currently owned by institutional investors.

Perrigo Stock Performance

NYSE:PRGO opened at $15.83 on Tuesday. The stock has a market cap of $2.20 billion, a P/E ratio of -1.27, a PEG ratio of 1.84 and a beta of 0.69. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. The business’s 50-day moving average price is $14.62 and its two-hundred day moving average price is $12.46. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $22.01.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. Perrigo’s revenue was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts predict that Perrigo Company plc will post 2.17 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were given a dividend of $0.29 per share. The ex-dividend date was Friday, August 28th. This represents a $1.16 annualized dividend and a yield of 7.3%. Perrigo’s payout ratio is presently -9.27%.

Analyst Upgrades and Downgrades

PRGO has been the subject of several analyst reports. Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. Wall Street Zen cut shares of Perrigo from a “strong-buy” rating to a “buy” rating in a report on Sunday, September 27th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Perrigo has a consensus rating of “Hold” and an average target price of $17.50.

About Perrigo

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.